Table 3.
Reference | Genetic disease | Culture approach | Study highlight |
---|---|---|---|
Nie et al. [130], 2018 | HBV | Co-culture of PSC-derived hepatic endoderm with MSC and HUVEC | Parallel comparison of PSC-derived hepatocyte-like cells (HLCs) and liver organoids (LOs). LOs are more susceptible to HBV viral infection and could be maintained longer in culture compared to HLC. |
LO HBV models exhibit cytopathic effects of HBV infection. | |||
De Crignis et al. [131], 2021 | HBV | ICO culture | HBV-infected organoid models exhibit various disease hallmarks, including cccDNA formation and HBS antigen expression. |
HBV integration is detectable in the HBV patient-derived organoids and unique gene signatures identified in the transcriptome profiles of HBV patient-derived organoids is enriched in HBV and HCC patient tissue. | |||
Li et al. [135], 2022 | HEV | ICO culture | Patient-derived fetal and adult organoids can be employed for modeling HEV infection via overexpression of in vitro–transcribed genomic RNA. |
The organoid model was employed to demonstrate that HEV infects both cholangiocytes and hepatocytes, and viruses were released from the apical surface of both cell types. | |||
Small-scale antiviral drug screens with the HEV organoids identify Brequinar and Homoharringtonine as potential new HEV therapeutics. | |||
a. Yang et al. [136], 2020 | SARS-CoV-2 | PSC-derived liver organoids | PSC-derived liver organoid was employed to demonstrate that SARS-CoV-2 virus can infect both hepatocytes and cholangiocyte . |
b. Richards et al. [137], 2022 | Single-cell transcriptome profiles of infected organoids show that the hepatocytes express higher levels of chemokines and cytokines than the cholangiocytesb. | ||
a. Yang et al. [136], 2020 | SARS-CoV-2 | Intra-hepatic cholangiocyte organoids | ICO organoid-derived hepatocyte and cholangiocyte organoids can be infected with SARS-CoV-2 virus. Infection induces the expression of immune-related genes in both cell types. |
b. Zhao et al. [138], 2020; Zhao et al. [139], 2023 | SARS-CoV-2 virus infection results in the downregulation of genes encoding junction proteins and bile transporters in cholangiocyte organoidsa. | ||
c. McCarron et al. [140], 2021 | ICOs derived from Non-alcoholic steatohepatitis (NASH) patient have increased UBD expression, and exhibits increased sensitivity to SARS-CoV-2 virus infectionC. |
HBV, hepatitis B virus; PSC, pluripotent stem cell; MSC, Mesenchymal Stem Cell; HUVEC, Human umbilical vein endothelial cell; ICO, intrahepatic cholangiocyte organoids; HBS, hepatitis B surface; HEV, hepatitis E virus.